Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis

Objective: To delineate the curative effect and safety of anti-fibrosis Chinese patent medicines (CPMs) combined with ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC). Methods: A literature search was conducted using PubMed, Web of Science, Embase, Cochrane Library, Wanfang database...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yufei, Shi, Ke, Chen, Jialiang, Wang, Xianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070848/
https://www.ncbi.nlm.nih.gov/pubmed/37025490
http://dx.doi.org/10.3389/fphar.2023.1159222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070848/
https://www.ncbi.nlm.nih.gov/pubmed/37025490
http://dx.doi.org/10.3389/fphar.2023.1159222

Ejemplares similares